|
|
|
|
Science Sparks @ ACTREC
|
 04th March 2024 |
Vol. No. 13 ; Issue No.620 |
|
|
Publications
|
|
1. Sengupta S, Biswas M, Gandhi KA, Gupta SK, Gera PB, Gota V, Sonawane A (2024). Preclinical evaluation of engineered L-asparaginase variants to improve the treatment of Acute Lymphoblastic Leukemia.43:101909 Translational Oncology.
2. Shetty T, Joshi P, Talole S, Nair S, Chaturvedi P (2024). Factors affecting drain output in oral carcinoma. Journal of Maxillofacial and Oral Surgery
3. Srinivasan S, Keerthivasagam S, Kumar S, Puri A (2024). ASO Author Reflections: Utilizing surveillance imaging techniques for detecting recurrences in patients with extremity sarcomas. Annals of Surgical Oncology. 31(3):2063-2064.
4. Qureshi S, Reddy S, Smriti V, Baheti A, Shah S, Channaswamy G, Prasad M, Parambil B, Gollamudi V, Panjwai P, Ramadwar M, Amin N, Kembhavi S (2024). Impact of surgical timing (primary, delayed, or second look) on surgical morbidity and outcomes in Malignant Germ Cell Tumor of the Ovary in children. Journal of Pediatric Surgery
5. Rao AR, Noronha V, Ramaswamy A, Kumar A, Pillai A, Sehgal A, Castelino R, Dhekale R, Jagtap P, Tripathi V, Satamkar S, Krishnamurthy J, Mahajan S, Daptardar A, Sonkusare L, Deodhar J, Ansari N, Vagal M, Mahajan P, Timmanpyati S, Nookala M, Chitre A, Kapoor A, Gota V, Banavali S, Badwe RA, Prabhash K. Assessing frailty in older Indian patients before cancer treatment: Comparative analysis of three scales and their implications for overall survival. Journal of Geriatric Oncology. 15(3):101736
6. Wadasadawala T, Joshi S, Rath S, Popat P, Sahay A, Gulia S, Bhargava P, Krishnamurthy R, Hoysal D, Shah J, Engineer M, Bajpai J, Kothari B, Pathak R, Jaiswal D, Desai S, Shet T, Patil A, Pai T, Haria P, Katdare A, Chauhan S, Siddique S, Vanmali V, Hawaldar R, Gupta S, Sarin R, Badwe R. Tata memorial centre evidence based management of breast cancer. Indian Journal of Cancer. 61(Suppl 1):S52-S79
7. Puranik AD, Choudhury S, Ghosh S, Dev ID, Ramchandani V, Uppal A, Bhosale V, Palsapure A, Rungta R, Pandey R, Khatri S, George G, Satamwar Y, Maske R, Agrawal A, Shah S, Purandare NC, Rangarajan V. Tata memorial centre evidence based use of nuclear medicine diagnostic and treatment modalities in cancer. Indian Journal of Cancer. 61(Suppl 1):S1-S28.
8. Saklani A, Kazi M, Desouza A, Sharma A, Engineer R, Krishnatry R, Gudi S, Ostwal V, Ramaswamy A, Dhanwat A, Bhargava P, Mehta S, Sundaram S, Kale A, Goel M, Patkar S, Vartey G, Kulkarni S, Baheti A, Ankathi S, Haria P, Katdare A, Choudhari A, Ramadwar M, Menon M, Patil P. Tata memorial centre evidence based management of colorectal cancer. Indian Journal of Cancer. 61(Suppl 1):S29-S51.
Thesis
Saket Vatsa Mishra. 2024. Understanding the molecular mechanism of leukemia resistance using cellular and pre-clinical model of leukemia resistance. (LIFE09201604017) (Guide: Dr.Shilpee Dutt)
|
|
|
|
|
Interesting Reads
|
|
Hardaker EL, Sanseviero E, Karmokar A, Taylor D, Milo M, Michaloglou C, Hughes A, Mai M, King M, Solanki A, Magiera L, Miragaia R, Kar G, Standifer N, Surace M, Gill S, Peter A, Talbot S, Tohumeken S, Fryer H, Mostafa A, Mulgrew K, Lam C, Hoffmann S, Sutton D, Carnevalli L, Calero-Nieto FJ, Jones GN, Pierce AJ, Wilson Z, Campbell D, Nyoni L, Martins CP, Baker T, Serrano de Almeida G, Ramlaoui Z, Bidar A, Phillips B, Boland J, Iyer S, Barrett JC, Loembé AB, Fuchs SY, Duvvuri U, Lou PJ, Nance MA, Gomez Roca CA, Cadogan E, Critichlow SE, Fawell S, Cobbold M, Dean E, Valge-Archer V, Lau A, Gabrilovich DI, Barry ST. The ATR inhibitor ceralasertib potentiates cancer checkpoint immunotherapy by regulating the tumor microenvironment. Nat Commun. 15(1): 1700, 2024.
|
|
|
Video of the Week
|
|
| Scalable Diet and Exercise Interventions for Cancer Prevention and Control |
|
| |
|
|
| |
|
|
|
|
Do You Know?
In 2015, FDA approved talimogene laherparepvec (T-VEC) for the treatment of some patients with metastatic melanoma that cannot be surgically removed
|
|
|
|
Cancer News
|
| |
|
The Rs 100 pill: How Tata Memorial’s new drug will prevent cancer comeback
|
|
Financial Express, 28/02/2024
|
|
Dr Indraneel Mittra, the lead scientist behind the TMH research, explained how their experiments involving human breast cancer cells implanted in mice elucidated the impact of different cancer treatments on chromatin levels. Remarkably, a combination of resveratrol and copper...
|
| |
|
ctDNA may guide who needs chemo after colorectal cancer surgery.
|
|
National Cancer Institute, 28/02/2024
|
|
In the study, the presence of fragments of genetic material that have escaped from tumors into the bloodstream, or circulating tumor DNA (ctDNA), seemed to predict which patients would benefit from the chemotherapy they receivedExit Disclaimer...
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
2019 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|
